119 related articles for article (PubMed ID: 33869915)
1. Identification of Bioactive SNM1A Inhibitors.
Buzon B; Grainger RA; Rzadki C; Huang SYM; Junop M
ACS Omega; 2021 Apr; 6(14):9352-9361. PubMed ID: 33869915
[TBL] [Abstract][Full Text] [Related]
2. The SNM1A DNA repair nuclease.
Baddock HT; Yosaatmadja Y; Newman JA; Schofield CJ; Gileadi O; McHugh PJ
DNA Repair (Amst); 2020 Nov; 95():102941. PubMed ID: 32866775
[TBL] [Abstract][Full Text] [Related]
3. Structure-specific endonuclease activity of SNM1A enables processing of a DNA interstrand crosslink.
Buzon B; Grainger R; Huang S; Rzadki C; Junop MS
Nucleic Acids Res; 2018 Sep; 46(17):9057-9066. PubMed ID: 30165656
[TBL] [Abstract][Full Text] [Related]
4. Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer target.
Bielinski M; Henderson LR; Yosaatmadja Y; Swift LP; Baddock HT; Bowen MJ; Brem J; Jones PS; McElroy SP; Morrison A; Speake M; van Boeckel S; van Doornmalen E; van Groningen J; van den Hurk H; Gileadi O; Newman JA; McHugh PJ; Schofield CJ
Chem Sci; 2024 May; 15(21):8227-8241. PubMed ID: 38817593
[TBL] [Abstract][Full Text] [Related]
5. DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation.
Ishiai M; Kimura M; Namikoshi K; Yamazoe M; Yamamoto K; Arakawa H; Agematsu K; Matsushita N; Takeda S; Buerstedde JM; Takata M
Mol Cell Biol; 2004 Dec; 24(24):10733-41. PubMed ID: 15572677
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of squaramide and thiosquaramide inhibitors of the DNA repair enzyme SNM1A.
Berney M; Doherty W; Jauslin WT; T Manoj M; Dürr EM; McGouran JF
Bioorg Med Chem; 2021 Sep; 46():116369. PubMed ID: 34482229
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human SNM1A and SNM1B/Apollo DNA repair exonucleases.
Sengerová B; Allerston CK; Abu M; Lee SY; Hartley J; Kiakos K; Schofield CJ; Hartley JA; Gileadi O; McHugh PJ
J Biol Chem; 2012 Jul; 287(31):26254-67. PubMed ID: 22692201
[TBL] [Abstract][Full Text] [Related]
8. 5'-Phosphorylation Increases the Efficacy of Nucleoside Inhibitors of the DNA Repair Enzyme SNM1A.
Berney M; Manoj MT; Fay EM; McGouran JF
ChemMedChem; 2022 Mar; 17(5):e202100603. PubMed ID: 34905656
[TBL] [Abstract][Full Text] [Related]
9. Probing the Binding Requirements of Modified Nucleosides with the DNA Nuclease SNM1A.
Dürr EM; McGouran JF
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435514
[TBL] [Abstract][Full Text] [Related]
10. Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction.
Thongthip S; Bellani M; Gregg SQ; Sridhar S; Conti BA; Chen Y; Seidman MM; Smogorzewska A
Genes Dev; 2016 Mar; 30(6):645-59. PubMed ID: 26980189
[TBL] [Abstract][Full Text] [Related]
11. The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities.
Allerston CK; Lee SY; Newman JA; Schofield CJ; McHugh PJ; Gileadi O
Nucleic Acids Res; 2015 Dec; 43(22):11047-60. PubMed ID: 26582912
[TBL] [Abstract][Full Text] [Related]
12. FANCD2-associated nuclease 1, but not exonuclease 1 or flap endonuclease 1, is able to unhook DNA interstrand cross-links in vitro.
Pizzolato J; Mukherjee S; Schärer OD; Jiricny J
J Biol Chem; 2015 Sep; 290(37):22602-11. PubMed ID: 26221031
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM
Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543
[TBL] [Abstract][Full Text] [Related]
14. Two-Step Validation Approach for Tools To Study the DNA Repair Enzyme SNM1A.
Fay EM; Newton A; Berney M; El-Sagheer AH; Brown T; McGouran JF
Chembiochem; 2023 Jul; 24(13):e202200756. PubMed ID: 36917742
[TBL] [Abstract][Full Text] [Related]
15. Deploying solid-phase synthesis to access thymine-containing nucleoside analogs that inhibit DNA repair nuclease SNM1A.
Arbour CA; Fay EM; McGouran JF; Imperiali B
Org Biomol Chem; 2023 Jul; 21(28):5873-5879. PubMed ID: 37417819
[TBL] [Abstract][Full Text] [Related]
16. Interstrand Crosslink Repair as a Target for HDAC Inhibition.
Nikolova T; Kiweler N; Krämer OH
Trends Pharmacol Sci; 2017 Sep; 38(9):822-836. PubMed ID: 28687272
[TBL] [Abstract][Full Text] [Related]
17. The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy.
Guohui S; Lijiao Z; Rugang Z
Anticancer Agents Med Chem; 2015; 16(2):221-46. PubMed ID: 26299659
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
19. Differential role of base excision repair proteins in mediating cisplatin cytotoxicity.
Sawant A; Floyd AM; Dangeti M; Lei W; Sobol RW; Patrick SM
DNA Repair (Amst); 2017 Mar; 51():46-59. PubMed ID: 28110804
[TBL] [Abstract][Full Text] [Related]
20. New features on Pso2 protein family in DNA interstrand cross-link repair and in the maintenance of genomic integrity in Saccharomyces cerevisiae.
Munari FM; Guecheva TN; Bonatto D; Henriques JA
Fungal Genet Biol; 2013 Nov; 60():122-32. PubMed ID: 24076078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
